Mir SA - Search Results

1

Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer.

Mir SA, Dar A, Alshehri SA, Wahab S, Hamid L, Almoyad MAA, Ali T, Bader GN. Mir SA, et al. Pharmaceuticals (Basel). 2023 Jul 14;16(7):1004. doi: 10.3390/ph16071004. Pharmaceuticals (Basel). 2023. PMID: 37513916 Free PMC article. Review.

2

Polycystic ovarian syndrome-current pharmacotherapy and clinical implications.

Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, Amin F, Bader GN. Rashid R, et al. Among authors: mir sa. Taiwan J Obstet Gynecol. 2022 Jan;61(1):40-50. doi: 10.1016/j.tjog.2021.11.009. Taiwan J Obstet Gynecol. 2022. PMID: 35181044 Free article. Review.

3

Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review.

Mir SA, Hamid L, Bader GN, Shoaib A, Rahamathulla M, Alshahrani MY, Alam P, Shakeel F. Mir SA, et al. Molecules. 2022 Oct 5;27(19):6608. doi: 10.3390/molecules27196608. Molecules. 2022. PMID: 36235145 Free PMC article. Review.

4

Evaluation of the Safety and Efficacy of Ormeloxifene, a Selective Estrogen Receptor Modulator and Medroxyprogesterone Acetate in Women with Non-Structural Abnormal Uterine Bleeding: A Randomized Clinical Trial.

Mir SA, Ara R, Amin F, Malik A, Hamid L, Ali T, Bader GN, Wani SUD, Almuqbil M, Alshehri S, Alshehri AM, Shakeel F. Mir SA, et al. Medicina (Kaunas). 2022 Oct 22;58(11):1503. doi: 10.3390/medicina58111503. Medicina (Kaunas). 2022. PMID: 36363460 Free PMC article. Clinical Trial.

5

Flavonoids as promising molecules in the cancer therapy: An insight.

Mir SA, Dar A, Hamid L, Nisar N, Malik JA, Ali T, Bader GN. Mir SA, et al. Curr Res Pharmacol Drug Discov. 2023 Dec 8;6:100167. doi: 10.1016/j.crphar.2023.100167. eCollection 2024. Curr Res Pharmacol Drug Discov. 2023. PMID: 38144883 Free PMC article. Review.

6

Attenuation of paracetamol-induced hepatotoxicity in Ajuga bracteosa extract treated mice.

Ali T, Jan I, Bashir R, Mir SA, Ali S, Bader GN. Ali T, et al. Among authors: mir sa. Heliyon. 2024 Jul 2;10(13):e33998. doi: 10.1016/j.heliyon.2024.e33998. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055821 Free PMC article.

7

Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine.

Ansari JA, Malik JA, Ahmed S, Bhat FA, Khanam A, Mir SA, Abouzied AS, Ahemad N, Anwar S. Ansari JA, et al. Among authors: mir sa. Pharmacology. 2023;108(6):504-520. doi: 10.1159/000531802. Epub 2023 Sep 25. Pharmacology. 2023. PMID: 37748454 Free article. Review.

8

Noni enhances the anticancer activity of cyclophosphamide and suppresses myelotoxicity and hepatotoxicity in tumor-bearing mice.

Ali M, Manjula SN, Mohiuddin I, Mruthunjaya K, Shakeel F, Mir SA, Wani SUD. Ali M, et al. Among authors: mir sa. J Cancer Res Clin Oncol. 2024 Apr 25;150(4):212. doi: 10.1007/s00432-024-05734-1. J Cancer Res Clin Oncol. 2024. PMID: 38662247 Free PMC article.

9

Integrated analysis of per- and polyfluoroalkyl substances and plasma lipidomics profiles in multi-ethnic Asian subjects for exposome research.

Narasimhan K, Vaitheeswari, Choi E, Chandran NS, Eriksson JG, Bendt AK, Torta F, Mir SA. Narasimhan K, et al. Among authors: mir sa. Environ Health. 2024 Nov 28;23(1):105. doi: 10.1186/s12940-024-01145-4. Environ Health. 2024. PMID: 39609840 Free PMC article.

10

LC-MS, NMR analysis, molecular docking and simulation studies of phytoestrogen from Senna occidentalis L. pods against PPAR-α protein.

Patra S, Mir SA, Khatun A, Karan P, Seal T, Ghosh A, Ghosh K, Pradhan S, Nayak B, Dhara B, Chakrabarti S. Patra S, et al. Among authors: mir sa. Nat Prod Res. 2024 Nov 22:1-10. doi: 10.1080/14786419.2024.2430323. Online ahead of print. Nat Prod Res. 2024. PMID: 39576098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters